US CBO examines per capita health disparity
This article was originally published in Clinica
The difference in healthcare spending among the 50 US states remains largely unexplained, a report from the Congressional Budget Office (CBO) says. However, variations in the use of medical technology plays a role.
You may also be interested in...
The fast-dissolving tablet will launch in early March. Its list price is not available but based on pricing for Allergan’s oral anti-CGRP Ubrelvy, ICER has said Biohaven’s rimegepant is likely to be cost-effective.
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.